Atrial fibrillation: diagnosis and management

recurrences or • it is recommended in section 1.2 on assessment of stroke and bleeding risks and section 1.6 on stroke prevention. [2006, amended 2014] 1.8.10 In people with new-onset atrial fibrillation, if there is uncertainty over the precise time since onset, offer oral anticoagulation as for persistent atrial fibrillation (see section 1.2 on assessment of stroke and bleeding risks and section 1.6 stroke prevention). [2006, amended 2014] 1.9 Initial management of stroke and atrial fibrillation 1.9.1 For guidance on the initial management of stroke and atrial fibrillation see recommendation 1.4.17 in NICE's guideline on stroke and transient ischaemic attack in over 16s. [2014] 1.10 Preventing and managing postoperative atrial fibrillation Preventing postoperative atrial fibrillation 1.10.1 In people having cardiothoracic surgery: • reduce the risk of postoperative atrial fibrillation by offering 1 of the following: － amiodarone － a standard beta-blocker (that is, a beta-blocker other than sotalol) － a rate-limiting calcium-channel blocker (diltiazem or verapamil) • do not offer digoxin. [2006, amended 2014] In April 2021, this was an off-label use of diltiazem. See NICE's information on prescribing medicines. 1.10.2 In people having cardiothoracic surgery who are already on beta-blocker therapy, continue this treatment unless contraindications develop (such as
